Corvia Medical Revenue and Competitors

Tewksbury,

Location

#7646

Growjo Ranking

Estimated Revenue & Valuation

  • Corvia Medical's estimated annual revenue is currently $5.5M per year.(i)
  • Corvia Medical's estimated revenue per employee is $125,500
  • Corvia Medical's total funding is $105M.

Employee Data

  • Corvia Medical has 44 Employees.(i)
  • Corvia Medical grew their employee count by 7% last year.

Corvia Medical's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
SVP and Chief Medical OfficerReveal Email/Phone
3
VP, Quality Assurance and Regulatory AffairsReveal Email/Phone
4
VP Therapy DevelopmentReveal Email/Phone
5
VP R+DReveal Email/Phone
6
VP MarketingReveal Email/Phone
7
VP, R&D and OperationsReveal Email/Phone
8
VP Therapy DevelopmentReveal Email/Phone
9
Director QualityReveal Email/Phone
10
SVP and Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Corvia Medical?

Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The IASD System II is the worldᅢᄁ¬ツᆲ¬トᄁs first transcatheter device approved by the European Union to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction. Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, and Lumira Capital. In the United States, the IASD System is an investigational device and not available for commercial distribution or sale. For more information, please visit http://www.corviamedical.com

keywords:N/A

$105M

Total Funding

44

Number of Employees

$5.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Corvia Medical News

2022-03-30 - Corvia Medical reports encouraging results from trial of atrial ...

[Image from Corvia Medical] Corvia Medical today announced positive data from the global phase III clinical trial of its atrial shunt in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.8M5213%N/A
#2
$14.1M5435%N/A
#3
$17.8M56-7%N/A
#4
$15.7M603%N/A
#5
$35M709%N/A